Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, School of Public Health, Guizhou Medical University, Guiyang, China.
Department of Laboratory, Guiyang Public Health Clinical Center, Guiyang, China.
Immun Inflamm Dis. 2024 Nov;12(11):e70029. doi: 10.1002/iid3.70029.
As the social economy has developed and population mobility has increased, differences in the Human immunodeficiency virus type 1 (HIV-1) genotype distribution among men who have sex with men (MSM) have become apparent in the provinces and cities across China. The high variability and drug resistance characteristics of HIV-1 can lead to the widespread spread of resistant strains, which may also result in antiretroviral therapy failure and an increase in the mortality rate.
The genotypic drug resistance characteristics and HIV-1 transmission risks among HIV-1-infected MSM in Guiyang, Guizhou Province were analyzed in the current study. The aim of the study was to provide a scientific basis for preventing the spread of HIV-1 strains among MSM and develop intervention measures.
A cross-sectional study was conducted at the Guiyang Public Health Clinical Center. A total of 181 HIV-1-infected MSM who not received treatment at the center between 1 January 2020 and 31 December 2022 were selected. The HIV-1 pol region gene fragment, including the protease and reverse transcriptase regions, was amplified by nested PCR and RT-PCR. The maximum likelihood method was used to construct a phylogenetic tree for analyzing the HIV-1 genotypes in MSM. HIV-1 genotypic resistance was evaluated using the Stanford University HIV drug resistance database. A molecular transmission network of HIV was constructed and the risk of HIV-1 transmission was determined.
We successfully amplified 173 pol gene sequences from blood samples obtained from 181 patients. The main subtype was CRF07_BC (60.69% [105/173]), followed by CRF01_AE (26.59% [46/173]), CRF08_BC (4.05% [7/173]), CRF55_01B (4.62% [8/173]), B (3.47% [6/173]), and C (0.58% [1/173]). The distribution of HIV-1 genotypes in MSM showed that there was a significant difference in the genotype composition of HIV-1-infected MSM according to registered residences and ages (p < .05). The CRF55_01B subtype accounted for the lowest proportion in Guiyang City and individuals >30 years of age. Multivariate logistic regression analysis of risk factors for drug resistance in HIV-1-infected MSM showed that the overall prevalence of pretreatment drug-resistant species was 12.72% (22/173), and age >30 years, CRF55_01B subtype, and CD4 T lymphocyte count >350 cells/mm were risk factors for drug resistance in MSM HIV-1 strains. Among the pretreatment drug-resistant species, non-nucleoside reverse transcriptase inhibitors with ≥1 drug resistant-species accounted for 9.25% (16/173), followed by protease inhibitors at 4.05% (7/173) and nucleoside reverse transcriptase inhibitors at 1.73% (3/173). Non-nucleoside reverse transcriptase inhibitors resistant to the CRF07_BC and CRF01_AE genotypes were predominant. The CRF55_01B genotype was shown to be most likely to carry the V179E mutation. The molecular network included CRF07_BC and B genotypes. The results of multi-factor logistic regression analysis on the factors affecting the rate of joining the network showed that individuals >30 years of age were less likely to join the network compared to those individuals <30 years of age.
The distribution of HIV-1 genotypes among MSM in Guiyang is diverse and complex. The main genotypes were shown to be CRF07_BC and CRF01_AE. The drug resistance mutation rate is high and pretreatment drug-resistant species is at a moderate level of prevalence, with NNRTIs being the most common site for drug resistance mutations. The CRF07_BC subtype and patients <30 years of age were identified as the key intervention targets in Guiyang based on the molecular transmission network. Patients should routinely undergo drug resistance testing before starting antiretroviral therapy to avoid virologic treatment failure and prevent the spread of HIV-1-resistant strains in MSM.
随着社会经济的发展和人口流动的增加,中国各省市男男性行为人群(MSM)中人类免疫缺陷病毒 1 型(HIV-1)基因型分布的差异变得明显。HIV-1 的高度变异性和耐药性特征可能导致耐药株的广泛传播,这也可能导致抗逆转录病毒治疗失败和死亡率增加。
本研究旨在分析贵州省贵阳市 HIV-1 感染的 MSM 中 HIV-1 基因型的耐药特征和 HIV-1 传播风险,为预防 MSM 中 HIV-1 株的传播和制定干预措施提供科学依据。
采用横断面研究方法,选取 2020 年 1 月 1 日至 2022 年 12 月 31 日期间在贵阳市公共卫生临床救治中心未接受治疗的 181 例 HIV-1 感染的 MSM。采用巢式 PCR 和 RT-PCR 扩增 HIV-1 pol 区基因片段,包括蛋白酶和逆转录酶区。最大似然法构建 MSM 中 HIV-1 基因型的系统进化树。采用斯坦福大学 HIV 耐药性数据库评估 HIV-1 基因型耐药性。构建 HIV 分子传播网络,确定 HIV-1 传播风险。
成功从 181 例患者的血液样本中扩增出 173 个 pol 基因序列。主要亚群为 CRF07_BC(60.69%[105/173]),其次是 CRF01_AE(26.59%[46/173])、CRF08_BC(4.05%[7/173])、CRF55_01B(4.62%[8/173])、B(3.47%[6/173])和 C(0.58%[1/173])。MSM 中 HIV-1 基因型的分布表明,根据登记居住地和年龄,HIV-1 感染的 MSM 中 HIV-1 基因型的构成存在显著差异(p<0.05)。在贵阳市,CRF55_01B 亚型在年龄>30 岁的个体中所占比例最低。多因素 logistic 回归分析 HIV-1 感染的 MSM 中耐药的危险因素显示,整体预处理耐药种的比例为 12.72%(22/173),年龄>30 岁、CRF55_01B 亚型和 CD4 T 淋巴细胞计数>350 个/mm3 是 MSM HIV-1 株耐药的危险因素。在预处理耐药种中,非核苷类逆转录酶抑制剂中≥1 种耐药种的比例为 9.25%(16/173),其次是蛋白酶抑制剂(4.05%[7/173])和核苷类逆转录酶抑制剂(1.73%[3/173])。非核苷类逆转录酶抑制剂对 CRF07_BC 和 CRF01_AE 基因型的耐药性为主。CRF55_01B 基因型最有可能携带 V179E 突变。分子网络包括 CRF07_BC 和 B 基因型。多因素 logistic 回归分析影响加入网络率的因素的结果显示,与年龄<30 岁的个体相比,年龄>30 岁的个体加入网络的可能性较小。
贵阳市 MSM 中 HIV-1 基因型分布多样且复杂,主要基因型为 CRF07_BC 和 CRF01_AE。耐药突变率高,预处理耐药种处于中等流行水平,NNRTIs 是耐药突变最常见的部位。基于分子传播网络,确定 CRF07_BC 亚型和年龄<30 岁的个体为贵阳市的关键干预目标。患者在开始抗逆转录病毒治疗前应常规进行耐药性检测,以避免病毒学治疗失败和预防 MSM 中 HIV-1 耐药株的传播。